Search

Kamal El Bissati

from Chicago, IL
Age ~54

Kamal Bissati Phones & Addresses

  • Chicago, IL
  • Bronx, NY
  • 17 Willis St, Bristol, CT 06010 (860) 314-0236
  • 418 Farmington Ave, New Britain, CT 06053 (860) 827-1308
  • Avon, CT
  • 418 Farmington Ave APT A5, New Britain, CT 06053 (860) 416-7790

Work

Company: Fulbright commission Sep 2017 Position: Fulbright us scholar

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Sorbonne Université 1996 to 2001 Specialities: Philosophy

Skills

College Teaching • Cell Culture • Cell Biology • Biotechnology • Biochemistry • Higher Education

Industries

Higher Education

Resumes

Resumes

Kamal Bissati Photo 1

Assistant Professor

View page
Location:
Chicago, IL
Industry:
Higher Education
Work:
Fulbright Commission
Fulbright Us Scholar

Albert Einstein College of Medicine Jan 2008 - Jun 2010
Instructor

University of Chicago Jan 2008 - Jun 2010
Assistant Professor

Uconn Health Jul 2002 - Jan 2008
Postdoctoral Fellow

Pierre and Marie Curie University & Ecole Normale Supérieure Sep 1996 - Jan 2001
Phd
Education:
Sorbonne Université 1996 - 2001
Doctorates, Doctor of Philosophy, Philosophy
Skills:
College Teaching
Cell Culture
Cell Biology
Biotechnology
Biochemistry
Higher Education

Publications

Us Patents

Conjugate Constructs, Delivery, And Use For Treatment Of Disease

View page
US Patent:
8575126, Nov 5, 2013
Filed:
Jun 27, 2012
Appl. No.:
13/507427
Inventors:
Rima McLeod - Chicago IL, US
Bo Shiun Lai - Chicago IL, US
William Witola - Chicago IL, US
Kamal El Bissati - Chicago IL, US
Ernest Mui - Chicago IL, US
Hong Moulton - Corvallis OR, US
Jonathan B Rothbard - Menlo Park CA, US
Jon D Moulton - Corvallis OR, US
International Classification:
C12N 15/113
C07H 21/04
US Classification:
514 44A, 536 245
Abstract:
Pharmaceutical formulations of antisense peptide-conjugated phosphorodiamidate morpholino olgomers and methods of use for treatment of apicomplexan infections are disclosed. The invention is particularly directed to treatment of infections.

Vaccines Against Toxoplasma Gondii

View page
US Patent:
20130273094, Oct 17, 2013
Filed:
Nov 3, 2011
Appl. No.:
13/823668
Inventors:
Rima McLeod - Chicago IL, US
Tze Guan Tan - Cambridge MA, US
Jeffery L. Alexander - San Diego CA, US
Hua Cong - Shandong, CN
William H. Witola - Auburn AL, US
Kamal El Bissati - Chicago IL, US
Ernest J. Mui - Chicago IL, US
Steven G. Reed - Bellevue WA, US
Assignee:
THE UNIVERSITY OF CHICAGO - Chicago IL
PAXVAX, INC. - San Diego CA
INFECTIOUS DISEASE RESEARCH INSTITUTE - Seattle WA
International Classification:
A61K 39/002
US Classification:
4241911
Abstract:
Vaccines are disclosed against parasites. The vaccines include peptides in an immunological composition. In particular, the parasite is

Use Of Conditional Plasmodium Strains Lacking Nutrient Transporters In Malaria Vaccination

View page
US Patent:
8128921, Mar 6, 2012
Filed:
Jul 11, 2007
Appl. No.:
11/827282
Inventors:
Choukri Ben Mamoun - Farmington CT, US
Kamal El Bissati - Chicago IL, US
Assignee:
University of Connecticut - Farmington CT
International Classification:
A01N 63/00
A01N 65/00
A61K 48/00
A61K 39/38
US Classification:
424 931, 424 932, 424 9321, 4241841, 4242651, 4242681, 4242691
Abstract:
The present invention relates to a malaria vaccine for administration to a host comprising an attenuated malarial parasite with a gene which has been rendered non-functional, wherein the gene, when present in naturally occurring form, encodes a protein necessary for continued in vivo survival and proliferation of the parasite and for infection of host red blood cells. The invention further relates to a malaria vaccine in which a gene that encodes a nutrient transporter protein has been rendered non-functional.

Toxoplasma Gondii Vaccines And Their Use

View page
US Patent:
20200289629, Sep 17, 2020
Filed:
Jun 3, 2020
Appl. No.:
16/892083
Inventors:
Rima MCLEOD - Chicago IL, US
Kamal EL BISSATI - Chicago IL, US
Ying ZHOU - Chicago IL, US
Jeff ALEXANDER - Redwood City CA, US
Lo VANG - Redwood City CA, US
Steve REED - Seattle WA, US
Sara M. PAULILLO - Riehen, CH
Senthil K. RAMAN - Riehen, CH
Peter BURKHARD - Riehen, CH
Mariane MELO - Cambridge MA, US
Darrel IRVINE - Cambridge MA, US
Ron WEISS - Cambridge MA, US
Yuan ZHANG - Cambridge MA, US
Alessandro SETTE - La Jolla CA, US
John SIDNEY - La Jolla CA, US
Brian D. LIVINGSTON - La Jolla CA, US
Hernan LORENZI - Rockville MD, US
International Classification:
A61K 39/002
A61P 33/02
A61K 9/00
A61K 39/012
Abstract:
Disclosed herein are polynucleotides encoding multi-epitope polypeptides and assemblies thereof, and their use for treating or limiting infection.

Toxoplasma Gondii Vaccines And Their Use

View page
US Patent:
20190282679, Sep 19, 2019
Filed:
Apr 14, 2017
Appl. No.:
16/094394
Inventors:
Rima MCLEOD - Chicago IL, US
Kamal EL BISSATI - Chicago IL, US
Ying ZHOU - Chicago IL, US
Jeff ALEXANDER - Redwood City CA, US
Lo VANG - Redwood City CA, US
Steve REED - Seattle WA, US
Sara M. PAULILLO - Riehen, CH
Senthil K. RAMAN - Riehen, CH
Peter BURKHARD - Riehen, CH
Mariane MELO - Cambridge MA, US
Darrel IRVINE - Cambridge MA, US
Ron WEISS - Cambridge MA, US
Yuan ZHANG - Cambridge MA, US
Alessandro SETTE - La Jolla CA, US
John SIDNEY - La Jolla CA, US
Brian D. LIVINGSTON - La Jolla CA, US
Hernan LORENZI - Rockville MD, US
International Classification:
A61K 39/002
A61K 9/00
A61P 33/02
Abstract:
Disclosed herein are polynucleotides encoding multi-epitope polypeptides and assemblies thereof, and their use for treating or limiting infection.
Kamal El Bissati from Chicago, IL, age ~54 Get Report